Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of 3D Systems Corporation regarding a class action lawsuit due to alleged misleading statements and omissions made by the company during the specified class period [1][2]. Summary by Sections Allegations - The complaint alleges that 3D Systems Corporation understated the impact of weakened customer spending on its business while overstating its resilience in challenging industry conditions [1]. - It is also claimed that updated milestone criteria in the partnership with United Therapeutics Corporation would negatively affect the revenue from the company's regenerative medicine program [1]. - As a result, the company's public statements were materially false and misleading throughout the relevant period [1]. Class Action Details - The class period for the lawsuit is from August 13, 2024, to May 12, 2025 [1]. - Shareholders are encouraged to register for the class action by the deadline of August 12, 2025, to potentially be appointed as lead plaintiffs [2]. - There is no cost or obligation for shareholders to participate in the case [2]. Law Firm Background - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting the rights of investors who have suffered due to deceit, fraud, and illegal business practices [3]. - The firm aims to ensure that companies adhere to responsible business practices and seeks recovery for investors who incurred losses due to misleading statements or omissions [3].

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against 3D Systems Corporation due to alleged violations of federal securities laws, encouraging affected investors to come forward before the August 12, 2025 deadline for lead plaintiff applications in a federal securities class action [2][4]. Financial Performance - 3D Systems reported Q4 2024 non-GAAP earnings-per-share of -$0.19, missing consensus estimates by $0.08, with sales revenue of $111 million, reflecting a 3.4% year-over-year decline [5]. - For the full year 2024, the company reported sales of $440.1 million, a decrease of 10% compared to the previous year, attributed to lower hardware systems sales due to macroeconomic factors [5]. - In Q1 2025, 3D Systems reported revenue of $94.5 million, down 8% year-over-year, and a net loss of $37 million, or $0.28 per share, more than doubling the loss from Q1 2024 [6]. Stock Price Reaction - Following the Q4 2024 results announcement, 3D Systems' stock price fell by $0.57, or 20.96%, closing at $2.15 per share [5]. - After the Q1 2025 results were released, the stock price dropped by $0.68, or 26.6%, to close at $1.87 per share [7]. Allegations and Legal Context - The complaint against 3D Systems alleges that the company and its executives made false or misleading statements regarding the impact of weakened customer spending and the revenue from its Regenerative Medicine Program [4]. - The firm is encouraging anyone with information regarding 3D Systems' conduct to contact them, including whistleblowers and former employees [8].

NEW YORK, June 20, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in 3D Systems Corporation ("3D Systems Corporation" or the "Company") (NYSE: DDD) of a class action securities lawsuit.CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of 3D Systems Corporation investors who were adversely affected by alleged securities fraud between August 13, 2024 and May 12, 2025. Follow the link below to get more information and be contacted by a member of our team:https://zlk.com/pslra-1/3d- ...

NEW YORK, June 19, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in 3D Systems Corporation ("3D Systems Corporation" or the "Company") (NYSE: DDD) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of 3D Systems Corporation investors who were adversely affected by alleged securities fraud between August 13, 2024 and May 12, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra ...

NEW YORK, June 19, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of 3D Systems Corporation (NYSE: DDD).Shareholders who purchased shares of DDD during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.CONTACT US HERE:https://securitiesclasslaw.com/securities/3d-systems-corporation-loss-submission-form/?id=153528&from=4CLASS PERIOD: August 13, ...

Core Viewpoint - A securities class action lawsuit has been filed against 3D Systems Corporation for allegedly making materially false and misleading statements during the Class Period from August 13, 2024, to May 12, 2025 [1][2]. Financial Performance - 3D Systems reported disappointing financial results for Q4 and full-year 2024, with a non-GAAP EPS of -$0.19, missing consensus by $0.08 per share [9]. - Sales revenue for Q4 2024 was $111 million, down 3.4% year-over-year, and missed estimates by $4.17 million [9]. - Full-year 2024 revenue totaled $440.1 million, reflecting a 10% decline from the prior year, primarily due to weaker hardware system sales [9]. - A $9 million revenue reduction in Q4 was attributed to changes in accounting estimates related to the Regenerative Medicine Program [9]. Stock Price Reaction - Following the announcement of disappointing Q4 results on March 26, 2025, shares of 3D Systems fell by 20.96%, closing at $2.15 per share on March 27, 2025 [3]. - After the May 12, 2025 press release regarding Q1 2025 results, the stock price dropped by $0.68 per share, or 26.6%, closing at $1.87 per share on May 13, 2025 [5]. Issues Raised in the Lawsuit - The lawsuit alleges that 3D Systems understated the impact of weakened customer spending and overstated its resilience amid challenging industry conditions [9]. - Revised milestone criteria in the United Partnership are expected to adversely affect revenues from the Regenerative Medicine Program [9]. - The company's public statements were deemed materially misleading due to these factors [9].

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against 3D Systems Corporation for alleged violations of federal securities laws, with a deadline for investors to seek lead plaintiff status by August 12, 2025 [3][5]. Financial Performance - 3D Systems reported Q4 2024 non-GAAP earnings-per-share of -$0.19, missing consensus estimates by $0.08, and sales revenue of $111 million, reflecting a year-over-year decline of 3.4% [6]. - For the full year 2024, the company reported sales of $440.1 million, a decrease of 10% compared to the previous year, attributed to lower hardware systems sales due to macroeconomic factors [6]. - In Q1 2025, 3D Systems reported revenue of $94.5 million, down 8% year-over-year, and a net loss of $37 million, or $0.28 per share, more than doubling the loss from Q1 2024 [8]. Stock Price Reaction - Following the Q4 2024 results announcement, 3D Systems' stock price fell by $0.57, or 20.96%, closing at $2.15 per share [7]. - After the Q1 2025 results were released, the stock price dropped by $0.68, or 26.6%, closing at $1.87 per share [9]. Allegations and Legal Context - The complaint against 3D Systems alleges that the company and its executives made false or misleading statements regarding customer spending and the impact on the company's business, as well as the revenue from its Regenerative Medicine Program [5]. - The firm encourages anyone with information regarding 3D Systems' conduct to come forward, including whistleblowers and former employees [11].

Core Viewpoint - 3D Systems has announced the issuance of $92 million in convertible senior secured notes, which will close on June 23, 2025, to strengthen its financial position and facilitate the repurchase of existing debt and shares [1][2]. Group 1: Notes Issuance Details - The notes will have a 5.875% interest rate, maturing on June 15, 2030, and will be convertible into cash, shares, or a combination at the option of the company [2][3]. - The initial conversion rate is set at 445.6328 shares per $1,000 principal amount, translating to an initial conversion price of approximately $2.24 per share, representing a 20% premium over the last reported stock price of $1.87 [3]. Group 2: Repurchase Plans - Proceeds from the notes will be used to repurchase a portion of the outstanding 0% convertible senior notes due 2026 and to buy back approximately $15 million worth of common stock [5]. - The company has negotiated to repurchase approximately $180 million in aggregate principal amount of the 2026 notes and may continue repurchasing after the notes' closing [6]. Group 3: Stock Repurchase Transactions - 3D Systems plans to repurchase around 8 million shares of its common stock from purchasers of the notes at a price of $1.87 per share, which matches the closing price on June 17, 2025 [7].

Core Viewpoint - A class action lawsuit has been filed against 3D Systems Corporation for alleged violations of federal securities laws, claiming that the company made materially false and misleading statements regarding its business and operations during the specified class period [1][2][3]. Group 1: Lawsuit Details - The lawsuit seeks to recover damages for all individuals and entities that purchased or acquired 3D Systems securities between August 13, 2024, and May 13, 2025 [2]. - Allegations include that 3D Systems understated the impact of weakened customer spending and overstated its resilience in challenging industry conditions [3]. - The complaint also states that updated milestone criteria in the United Partnership would negatively affect the Company's Regenerative Medicine Program revenue [3]. Group 2: Next Steps for Investors - Investors who suffered losses in 3D Systems have until August 12, 2025, to request to be appointed as lead plaintiff in the case [4]. - Participation in any recovery does not require serving as lead plaintiff [4]. Group 3: Legal Representation - Bronstein, Gewirtz & Grossman, LLC operates on a contingency fee basis, meaning they will only seek reimbursement for expenses and attorneys' fees if successful [5]. - The firm has a history of recovering hundreds of millions of dollars for investors in securities fraud class actions [6].

Core Viewpoint - Rosen Law Firm has announced a class action lawsuit on behalf of purchasers of 3D Systems Corporation securities during the specified Class Period, indicating potential legal issues for the company and its investors [1][5]. Group 1: Class Action Details - The class action lawsuit is filed for securities purchased between August 13, 2024, and May 12, 2025, and investors may be entitled to compensation without upfront costs through a contingency fee arrangement [2][5]. - Investors wishing to serve as lead plaintiff must file a motion by August 12, 2025, and a lead plaintiff will represent other class members in the litigation [3][5]. Group 2: Allegations Against 3D Systems - The lawsuit claims that 3D Systems made false and misleading statements regarding its business resilience and the impact of weakened customer spending [5]. - It is alleged that the company overstated its resilience in challenging industry conditions and failed to disclose negative impacts on its Regenerative Medicine Program revenue due to updated milestone criteria in a partnership with United Therapeutics Corporation [5]. - The lawsuit asserts that these misleading public statements resulted in investor damages when the true details became known [5]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including the largest securities class action settlement against a Chinese company at the time [4]. - The firm has been consistently ranked among the top firms for securities class action settlements and has recovered hundreds of millions of dollars for investors [4]. - In 2019, the firm secured over $438 million for investors, showcasing its effectiveness in representing investor rights [4].